The Use of Contrast-Enhanced Sonography for Therapy Monitoring of Metastatic Lymph Nodes: A Systematic Review
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Ferlay, J.; Colombet, M.; Soerjomataram, I.; Mathers, C.; Parkin, D.; Piñeros, M.; Znaor, A.; Bray, F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer 2019, 144, 1941–1953. [Google Scholar] [CrossRef]
- Di Credico, G.; Polesel, J.; Dal Maso, L.; Pauli, F.; Torelli, N.; Luce, D.; Radoi, L.; Matsuo, K.; Serraino, D.; Brennan, P.; et al. Alcohol drinking and head and neck cancer risk: The joint effect of intensity and duration. Br. J. Cancer 2020, 123, 1456–1463. [Google Scholar] [CrossRef] [PubMed]
- Di Credico, G.; Edefonti, V.; Polesel, J.; Pauli, F.; Torelli, N.; Serraino, D.; Negri, E.; Luce, D.; Stucker, I.; Matsuo, K.; et al. Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach. Oral Oncol. 2019, 94, 47–57. [Google Scholar] [CrossRef]
- Guidry, J.T.; Birdwell, C.E.; Scott, R.S. Epstein-Barr virus in the pathogenesis of oral cancers. Oral Dis. 2018, 24, 497–508. [Google Scholar] [CrossRef]
- Michaud, D.S.; Langevin, S.M.; Eliot, M.; Nelson, H.H.; Pawlita, M.; McClean, M.D.; Kelsey, K.T. High-risk HPV types and head and neck cancer. Int. J. Cancer 2014, 135, 1653–1661. [Google Scholar] [CrossRef]
- Chen, L.Y.; Weng, W.B.; Wang, W.; Chen, J.F. Analyses of High-Risk Factors for Cervical Lymph Node Metastasis in Laryngeal Squamous Cell Carcinoma and Establishment of Nomogram Prediction Model. Ear Nose Throat J. 2021, 100, 657S–662S. [Google Scholar] [CrossRef]
- Machiels, J.P.; Rene Leemans, C.; Golusinski, W.; Grau, C.; Licitra, L.; Gregoire, V. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2020, 31, 1462–1475. [Google Scholar] [CrossRef]
- Cooper, J.S.; Pajak, T.F.; Forastiere, A.A.; Jacobs, J.; Campbell, B.H.; Saxman, S.B.; Kish, J.A.; Kim, H.E.; Cmelak, A.J.; Rotman, M.; et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 2004, 350, 1937–1944. [Google Scholar] [CrossRef] [PubMed]
- Wang, H.; Zhao, Q.; Zhang, Y.; Zhang, Q.; Zheng, Z.; Liu, S.; Liu, Z.; Meng, L.; Xin, Y.; Jiang, X. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship with Human Papillomavirus. Front. Immunol. 2021, 12, 652054. [Google Scholar] [CrossRef] [PubMed]
- Kitamura, N.; Sento, S.; Yoshizawa, Y.; Sasabe, E.; Kudo, Y.; Yamamoto, T. Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma. Int. J. Mol. Sci. 2020, 22, 240. [Google Scholar] [CrossRef]
- Nindra, U.; Hurwitz, J.; Forstner, D.; Chin, V.; Gallagher, R.; Liu, J. A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma. Cancer Med. 2023, 12, 11234–11247. [Google Scholar] [CrossRef]
- Poulose, J.V.; Kainickal, C.T. Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials. World J. Clin. Oncol. 2022, 13, 388–411. [Google Scholar] [CrossRef]
- Leidner, R.; Crittenden, M.; Young, K.; Xiao, H.; Wu, Y.; Couey, M.A.; Patel, A.A.; Cheng, A.C.; Watters, A.L.; Bifulco, C.; et al. Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma. J. Immunother. Cancer 2021, 9, e002485. [Google Scholar] [CrossRef]
- Plavc, G.; Strojan, P. Combining radiotherapy and immunotherapy in definitive treatment of head and neck squamous cell carcinoma: Review of current clinical trials. Radiol. Oncol. 2020, 54, 377–393. [Google Scholar] [CrossRef]
- Cacicedo, J.; Navarro, A.; Del Hoyo, O.; Gomez-Iturriaga, A.; Alongi, F.; Medina, J.A.; Elicin, O.; Skanjeti, A.; Giammarile, F.; Bilbao, P.; et al. Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: The point of view of the radiation oncologist. Br. J. Radiol. 2016, 89, 20160217. [Google Scholar] [CrossRef]
- Hanemaaijer, S.H.; Fazzi, M.; Steenbakkers, R.; Dorgelo, B.; van der Vegt, B.; Witjes, M.J.H.; van der Laan, B.; Oosting, S.F.; Stormezand, G.N.; Plaat, B.E.C. (18) F-FDG PET/CT for response evaluation of regional lymph nodes in 97 head and neck squamous cell carcinoma patients: Differences in the predictive value of residual disease after radiotherapy and chemoradiotherapy. Clin. Otolaryngol. 2020, 45, 805–810. [Google Scholar] [CrossRef]
- Iovoli, A.J.; Farrugia, M.K.; Ma, S.J.; Chan, J.M.; Markiewicz, M.R.; McSpadden, R.; Wooten, K.E.; Gupta, V.; Kuriakose, M.A.; Hicks, W.L., Jr.; et al. Role of Repeat PET/CT Imaging in Head and Neck Cancer Following Initial Incomplete PET/CT Response to Chemoradiation. Cancers 2021, 13, 1461. [Google Scholar] [CrossRef] [PubMed]
- Kunzel, J.; Strieth, S.; Wirth, G.; Bozzato, A. Ultrasound in the Re-Staging of Cervical Metastases after Chemoradiotherapy for Head and Neck Cancer. Ultraschall Med. 2018, 39, 659–666. [Google Scholar] [CrossRef]
- Lo, W.C.; Cheng, P.W.; Wang, C.T.; Shueng, P.W.; Hsieh, C.H.; Chang, Y.L.; Liao, L.J. The Effect of Radiotherapy on Ultrasound-Guided Fine Needle Aspiration Biopsy and the Ultrasound Characteristics of Neck Lymph Nodes in Oral Cancer Patients after Primary Treatment. PLoS ONE 2016, 11, e0149346. [Google Scholar] [CrossRef] [PubMed]
- Piscaglia, F.; Bolondi, L. Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: Retrospective analysis of 23188 investigations. Ultrasound Med. Biol. 2006, 32, 1369–1375. [Google Scholar] [CrossRef] [PubMed]
- Sidhu, P.S.; Cantisani, V.; Dietrich, C.F.; Gilja, O.H.; Saftoiu, A.; Bartels, E.; Bertolotto, M.; Calliada, F.; Clevert, D.A.; Cosgrove, D.; et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall Med. 2018, 39, e2–e44. [Google Scholar] [CrossRef]
- Dudau, C.; Hameed, S.; Gibson, D.; Muthu, S.; Sandison, A.; Eckersley, R.; Clarke, P.; Cosgrove, D.; Lim, A. Can contrast-enhanced ultrasound distinguish malignant from reactive lymph nodes in patients with head and neck cancers? Ultrasound Med. Biol. 2014, 40, 747–754. [Google Scholar] [CrossRef] [PubMed]
- Ding, S.; Xiong, P.; Zuo, J. Value of contrast-enhanced ultrasound in predicting early lymph-node metastasis in oral cancer. Dentomaxillofacial Radiol. 2022, 51, 20210293. [Google Scholar] [CrossRef] [PubMed]
- Wendl, C.; Müller, S.; Meier, J.; Fellner, C.; Eiglsperger, J.; Gosau, M.; Prantl, L.; Stroszczynski, C.; Jung, E.M. High resolution contrast-enhanced ultrasound and 3-tesla dynamic contrast-enhanced magnetic resonance imaging for the preoperative characterization of cervical lymph nodes: First results. Clin. Hemorheol. Microcirc. 2012, 52, 153–166. [Google Scholar] [CrossRef]
- Yu, M.; Liu, Q.; Song, H.-P.; Han, Z.-H.; Su, H.-L.; He, G.-B.; Zhou, X.-D. Clinical Application of Contrast- Enhanced Ultrasonography in Diagnosis of Superficial Lymphadenopathy. J. Ultrasound Med. 2010, 29, 735–740. [Google Scholar] [CrossRef]
- Cui, X.W.; Jenssen, C.; Saftoiu, A.; Ignee, A.; Dietrich, C.F. New ultrasound techniques for lymph node evaluation. World J. Gastroenterol. 2013, 19, 4850–4860. [Google Scholar] [CrossRef]
- Kunzel, J.; Brandenstein, M.; Zeman, F.; Symeou, L.; Platz Batista da Silva, N.; Jung, E.M. Multiparametric Ultrasound of Cervical Lymph Node Metastases in Head and Neck Cancer for Planning Non-Surgical Therapy. Diagnostics 2022, 12, 1842. [Google Scholar] [CrossRef] [PubMed]
- Lerchbaumer, M.H.; Wakonig, K.M.; Arens, P.; Dommerich, S.; Fischer, T. Quantitative Multiparametric Ultrasound (mpUS) in the Assessment of Inconclusive Cervical Lymph Nodes. Cancers 2022, 14, 1597. [Google Scholar] [CrossRef] [PubMed]
- Xin, L.; Yan, Z.; Zhang, X.; Zang, Y.; Ding, Z.; Xue, H.; Zhao, C. Parameters for Contrast-Enhanced Ultrasound (CEUS) of Enlarged Superficial Lymph Nodes for the Evaluation of Therapeutic Response in Lymphoma: A Preliminary Study. Med. Sci. Monit. 2017, 23, 5430–5438. [Google Scholar] [CrossRef]
- Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef]
- Nie, J.; Ling, W.; Yang, Q.; Jin, H.; Ou, X.; Ma, X. The Value of CEUS in Distinguishing Cancerous Lymph Nodes from the Primary Lymphoma of the Head and Neck. Front. Oncol. 2020, 10, 473. [Google Scholar] [CrossRef]
- Peng, J.; Pu, H.; Jia, Y.; Chen, C.; Ke, X.K.; Zhou, Q. Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer. Medicine 2021, 100, e25908. [Google Scholar] [CrossRef] [PubMed]
- Del Prete, M.; Di Sarno, A.; Modica, R.; Lassandro, F.; Giorgio, A.; Bianco, A.; Muto, M.; Gasperi, M.; Del Prete, F.; Colao, A.; et al. Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors. J. Endocrinol. Invest. 2017, 40, 1373–1380. [Google Scholar] [CrossRef]
- Guo, J.; Wang, B.H.; He, M.; Fu, P.; Yao, M.; Jiang, T. Contrast-enhanced ultrasonography for early prediction of response of neoadjuvant chemotherapy in breast cancer. Front. Oncol. 2022, 12, 1026647. [Google Scholar] [CrossRef]
- Kim, Y.; Kim, S.H.; Song, B.J.; Kang, B.J.; Yim, K.I.; Lee, A.; Nam, Y. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer. Korean J. Radiol. 2018, 19, 682–691. [Google Scholar] [CrossRef]
- Lee, Y.J.; Kim, S.H.; Kang, B.J.; Kim, Y.J. Contrast-Enhanced Ultrasound for Early Prediction of Response of Breast Cancer to Neoadjuvant Chemotherapy. Ultraschall Med. 2019, 40, 194–204. [Google Scholar] [CrossRef] [PubMed]
- Schirin-Sokhan, R.; Winograd, R.; Roderburg, C.; Bubenzer, J.; do Ó, N.C.; Guggenberger, D.; Hecker, H.; Trautwein, C.; Tischendorf, J.J. Response evaluation of chemotherapy in metastatic colorectal cancer by contrast enhanced ultrasound. World J. Gastroenterol. 2012, 18, 541–545. [Google Scholar] [CrossRef]
- Xue, C.; Huang, Y.; Huang, P.Y.; Yu, Q.T.; Pan, J.J.; Liu, L.Z.; Song, X.Q.; Lin, S.J.; Wu, J.X.; Zhang, J.W.; et al. Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma. Ann. Oncol. 2013, 24, 1055–1061. [Google Scholar] [CrossRef] [PubMed]
- Chen, Q.; Tang, L.; Liu, N.; Han, F.; Guo, L.; Guo, S.; Wang, J.; Liu, H.; Ye, Y.; Zhang, L.; et al. Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A phase 1, open-label, dose-escalation Study. Cancer Commun. 2018, 38, 66. [Google Scholar] [CrossRef]
- Ye, Z.; Huang, P.; Zhou, X.; Huang, Q.; Hu, Q.; Shui, Y.; Shen, L.; Lai, E.; Wei, Q. Parametric contrast-enhanced ultrasound as an early predictor of radiation-based therapeutic response for lymph node metastases of nasopharyngeal carcinoma. Mol. Clin. Oncol. 2014, 2, 666–672. [Google Scholar] [CrossRef]
- Han, X.; Jin, S.; Yang, H.; Zhang, J.; Huang, Z.; Han, J.; He, C.; Guo, H.; Yang, Y.; Shan, M.; et al. Application of conventional ultrasonography combined with contrast-enhanced ultrasonography in the axillary lymph nodes and evaluation of the efficacy of neoadjuvant chemotherapy in breast cancer patients. Br. J. Radiol. 2021, 94, 20210520. [Google Scholar] [CrossRef]
- Rossi, S.H.; Prezzi, D.; Kelly-Morland, C.; Goh, V. Imaging for the diagnosis and response assessment of renal tumours. World J. Urol. 2018, 36, 1927–1942. [Google Scholar] [CrossRef]
- Wu, X.; Tang, L.; Huang, W.; Huang, S.; Peng, W.; Hu, D. Contrast-enhanced ultrasonography and blue dye methods in detection of sentinel lymph nodes following neoadjuvant chemotherapy in initially node positive breast cancer. Arch. Gynecol. Obstet. 2020, 302, 685–692. [Google Scholar] [CrossRef] [PubMed]
- Hidaka, Y.; Arigami, T.; Osako, Y.; Desaki, R.; Hamanoue, M.; Takao, S.; Kirishima, M.; Ohtsuka, T. Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: A case report. World J. Surg. Oncol. 2022, 20, 193. [Google Scholar] [CrossRef] [PubMed]
- McCarville, M.; Coleman, J.; Guo, J.; Li, Y.; Li, X.; Honnoll, P.; Davidoff, A.; Navid, F. Use of Quantitative Dynamic Contrast-Enhanced Ultrasound to Assess Response to Antiangiogenic Therapy in Children and Adolescents with Solid Malignancies: A Pilot Study. AJR Am. J. Roentgenol. 2016, 206, 933–939. [Google Scholar] [CrossRef]
- Swiecicki, P.L.; Brennan, J.R.; Mierzwa, M.; Spector, M.E.; Brenner, J.C. Head and Neck Squamous Cell Carcinoma Detection and Surveillance: Advances of Liquid Biomarkers. Laryngoscope 2019, 129, 1836–1843. [Google Scholar] [CrossRef] [PubMed]
- Cao, Y.; Haring, C.T.; Brummel, C.; Bhambhani, C.; Aryal, M.; Lee, C.; Heft Neal, M.; Bhangale, A.; Gu, W.; Casper, K.; et al. Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma. Clin. Cancer Res. 2022, 28, 350–359. [Google Scholar] [CrossRef]
- Dermody, S.M.; Haring, C.T.; Bhambhani, C.; Tewari, M.; Brenner, J.C.; Swiecicki, P.L. Surveillance and Monitoring Techniques for HPV-Related Head and Neck Squamous Cell Carcinoma: Circulating Tumor DNA. Curr. Treat. Options Oncol. 2021, 22, 21. [Google Scholar] [CrossRef]
- Kogo, R.; Manako, T.; Iwaya, T.; Nishizuka, S.; Hiraki, H.; Sasaki, Y.; Idogawa, M.; Tokino, T.; Koide, A.; Komune, N.; et al. Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma. Cancer Med. 2022, 11, 3960–3968. [Google Scholar] [CrossRef]
Inclusion Criteria | Exclusion Criteria | |
---|---|---|
P (participants) |
|
|
I (intervention) |
|
|
C (comparisons) | not applicable | not applicable |
O (outcomes) |
| |
S (study design) |
|
|
Reference | Publication Year | Study Design | Primary Disease | Cohort Size | Contrast Agent |
---|---|---|---|---|---|
Ye et al. [40] | 2014 | prospective | Nasopharyngeal carcinoma | 67 | SonoVue (2.4 mL) |
Chen et al. [39] | 2018 | prospective | Nasopharyngeal carcinoma | 20 | SonoVue |
Han et al. [41] | 2021 | prospective | Breast carcinoma | 74/64 * | SonoVue (4 mL) |
Reference | Qualitative Parameters Analyzed | Significant Qualitative Parameters | Quantitative Parameters Analyzed | Significant Quantitative Parameters | Sensitivity * | Specificity * | Conclusions |
---|---|---|---|---|---|---|---|
Ye et al. [40] |
|
|
|
|
| ||
Chen et al. [39] |
|
|
|
|
| ||
Han et al. [41] |
|
|
|
|
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Rink, M.; Jung, E.-M.; Künzel, J. The Use of Contrast-Enhanced Sonography for Therapy Monitoring of Metastatic Lymph Nodes: A Systematic Review. Curr. Oncol. 2023, 30, 6734-6743. https://doi.org/10.3390/curroncol30070494
Rink M, Jung E-M, Künzel J. The Use of Contrast-Enhanced Sonography for Therapy Monitoring of Metastatic Lymph Nodes: A Systematic Review. Current Oncology. 2023; 30(7):6734-6743. https://doi.org/10.3390/curroncol30070494
Chicago/Turabian StyleRink, Maximilian, Ernst-Michael Jung, and Julian Künzel. 2023. "The Use of Contrast-Enhanced Sonography for Therapy Monitoring of Metastatic Lymph Nodes: A Systematic Review" Current Oncology 30, no. 7: 6734-6743. https://doi.org/10.3390/curroncol30070494
APA StyleRink, M., Jung, E.-M., & Künzel, J. (2023). The Use of Contrast-Enhanced Sonography for Therapy Monitoring of Metastatic Lymph Nodes: A Systematic Review. Current Oncology, 30(7), 6734-6743. https://doi.org/10.3390/curroncol30070494